TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12566477

Group type: EXPERIMENTAL
Intervention: Selenium supplement (200 micro g) for 20 weeks
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo for 20 weeks
Number of subjects: 189
Study: 10232443

Group type: EXPERIMENTAL
Intervention: Dithioerythritol (DTE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phosphate-buffered saline (PBS)
Number of subjects: 0
Study: 8714324

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 10
Study: 1721787

Group type: EXPERIMENTAL
Intervention: Combined drug (quinine/quinidine/cinchonine) high dose regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined drug (quinine/quinidine/cinchonine) low dose regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 0
Study: 6416399

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin 100 mg administered eight hourly
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of rectal indomethacin and cryoanalgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional intramuscular opiate analgesia
Number of subjects: 0
Study: 31063503

Group type: EXPERIMENTAL
Intervention: Monthly sulfadoxine-pyrimethamine and two doses of azithromycin (AZI-SP)
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Control (two doses of sulfadoxine-pyrimethamine)
Number of subjects: 1320
Study: 27631091

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg)
Number of subjects: 665

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 665
Study: 26458336

Group type: EXPERIMENTAL
Intervention: Cilostazol treatment after 90 days
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Serum uric acid (UA) levels
Number of subjects: 130
Study: 25073942

Group type: EXPERIMENTAL
Intervention: Decompression with Wallis implant
Number of subjects: 60

Group type: COMPARATOR
Intervention: Decompression alone
Number of subjects: 60
Study: 21785897

Group type: EXPERIMENTAL
Intervention: 15 g/kg of charcoal-barbecued meat (experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 g/kg of charcoal-barbecued meat (experiment 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Background urinary 3-OHBaP
Number of subjects: 0
Study: 19735233

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 30 mg
Number of subjects: 4270

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg
Number of subjects: 4270

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg
Number of subjects: 4270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4270

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR (all doses)
Number of subjects: 4270

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 4270
Study: 17718360

Group type: EXPERIMENTAL
Intervention: Sharp corners
Number of subjects: 0

Group type: COMPARATOR
Intervention: Shallow corners
Number of subjects: 0
Study: 15843763

Group type: EXPERIMENTAL
Intervention: Stimulant + fluvoxamine (STIM/FLV)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Stimulant + placebo (STIM/PL)
Number of subjects: 25
Study: 12093599

Group type: EXPERIMENTAL
Intervention: Alprazolam (1 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10597811

Group type: EXPERIMENTAL
Intervention: Anterior ankle-foot orthosis (AFO)
Number of subjects: 24
Study: 7733543

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 30
Study: 2254498

Group type: EXPERIMENTAL
Intervention: Hypnotic induction at the beginning of each session
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group receiving relaxation and breathing exercises
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Highly susceptible, hypnotically treated women
Number of subjects: 60
Study: 7001491

Group type: EXPERIMENTAL
Intervention: 600 mg proquazone per day
Number of subjects: 36

Group type: COMPARATOR
Intervention: 900 mg proquazone per day
Number of subjects: 36
Study: 31090181

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) with Powerbreathe®, performing eight series of 2 minutes each at 60% of maximum inspiratory pressure.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group performing the same training protocol but with the load maintained at 9 cmH2O.
Number of subjects: 26
Study: 28235523

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Total Intravenous Anesthesia (TIVA) with propofol-remifentanil
Number of subjects: 80
Study: 25499170

Group type: EXPERIMENTAL
Intervention: 2 weeks post-operative BRT test
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 4 weeks post-operative BRT test
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Pre-operative BRT test
Number of subjects: 38
Study: 25675721

Group type: EXPERIMENTAL
Intervention: Meldonium 1000 mg/day for 3 months during winter
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (K)
Number of subjects: 49
Study: 22473650

Group type: EXPERIMENTAL
Intervention: Negative emotion condition
Number of subjects: 28

Group type: COMPARATOR
Intervention: Neutral emotion condition
Number of subjects: 28
Study: 19422623

Group type: EXPERIMENTAL
Intervention: 40 mg of paroxetine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 17226851

Group type: EXPERIMENTAL
Intervention: Counseling intervention
Number of subjects: 21
Study: 15986766

Group type: EXPERIMENTAL
Intervention: Ketoconazole/Clindamycin
Number of subjects: 23

Group type: COMPARATOR
Intervention: Metronidazole/Nistatine
Number of subjects: 23
Study: 11260907

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery for colorectal cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional open procedures
Number of subjects: 0
Study: 9884857

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.2 mg intravenously
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 63
Study: 8021700

Group type: EXPERIMENTAL
Intervention: Hydroquinine hydrobromide (300 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2605070

Group type: EXPERIMENTAL
Intervention: i.v. omeprazole 40 mg 1 h before surgery
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: i.v. omeprazole 40 mg 3 h before surgery
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 163625

Group type: EXPERIMENTAL
Intervention: Intensive psychosocial inhospital treatment (mean length of stay 30 days)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Detoxification and after-care services (mean length of stay nine days)
Number of subjects: 58
Study: 30882901

Group type: EXPERIMENTAL
Intervention: Localized index node removal after neoadjuvant immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neoadjuvant immunotherapy
Number of subjects: 0
Study: 29206627

Group type: EXPERIMENTAL
Intervention: Pedometer plus website (goal-setting, feedback, disease-specific education, online community forum)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Pedometer alone
Number of subjects: 109
Study: 25303096

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention programme (fitness training and counselling on physical behaviour and sports participation) for 6 months
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention programme
Number of subjects: 57
Study: 23138384

Group type: EXPERIMENTAL
Intervention: Protocol A (imaging delay 4 s, 48 ml contrast medium)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Protocol B (imaging delay 8 s, 64 ml contrast medium)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Protocol C (imaging delay 12 s, 80 ml contrast medium)
Number of subjects: 29
Study: 21752507

Group type: EXPERIMENTAL
Intervention: Surgical removal of impacted lower third molars
Number of subjects: 285
Study: 19404219

Group type: EXPERIMENTAL
Intervention: PLCO intervention arm (screening for lung cancer)
Number of subjects: 77465

Group type: EXPERIMENTAL
Intervention: Model including predictors (older age, lower education, smoking history, etc.)
Number of subjects: 77465

Group type: EXPERIMENTAL
Intervention: Model excluding smoking variables
Number of subjects: 77465

Group type: EXPERIMENTAL
Intervention: Model excluding all nonradiographic variables
Number of subjects: 77465
Study: 16650679

Group type: EXPERIMENTAL
Intervention: Ophthalmic care personnel (including retina specialists, general ophthalmologists, nurses, and photographers) reading digital fundus images without additional training
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Retina specialists reading digital fundus images
Number of subjects: 12

Group type: COMPARATOR
Intervention: All readers compared with consensus of retina specialists
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Retina specialist group
Number of subjects: 12
Study: 15453547

Group type: EXPERIMENTAL
Intervention: Zaleplon (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11288794

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 9248374

Group type: EXPERIMENTAL
Intervention: Moi‐Stir swabs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lemon glycerin swabs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toothettes (pink sponge applicators) and water
Number of subjects: 0
Study: 8308716

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) capsules containing 20.0 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) capsules containing 40.0 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional ISDN tablets (5.0 mg each)
Number of subjects: 8
Study: 3822497

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Peroral mexiletine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo infusions
Number of subjects: 2
Study: 31680344

Group type: EXPERIMENTAL
Intervention: Lateral/panoramic view capsule (CapsoCam Plus)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Axial view capsule (PillCam SB3)
Number of subjects: 25
Study: 29746376

Group type: EXPERIMENTAL
Intervention: HIV-1 subtype A
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: HIV-1 subtype D
Number of subjects: 308

Group type: COMPARATOR
Intervention: HIV exposed uninfected
Number of subjects: 308
Study: 28836993

Group type: COMPARATOR
Intervention: Flucloxacillin 500 mg four times daily and placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flucloxacillin 500 mg four times daily and phenoxymethylpenicillin 500 mg four times daily
Number of subjects: 0
Study: 25625133

Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill resin composite SDR
Number of subjects: 86

Group type: COMPARATOR
Intervention: Resin composite CeramX mono+ only
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Class II restorations with SDR-CeramX mono+
Number of subjects: 86

Group type: COMPARATOR
Intervention: Class II restorations with CeramX mono+ only
Number of subjects: 86
Study: 23122973

Group type: EXPERIMENTAL
Intervention: Muscle relaxant (Group MR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No muscle relaxant (Group NMR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 120
Study: 21821642

Group type: EXPERIMENTAL
Intervention: Reiki treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 21
Study: 18673078

Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (physical exercise)
Number of subjects: 80
Study: 16309684

Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 1398

Group type: EXPERIMENTAL
Intervention: Last Menstruation Period (LMP)
Number of subjects: 1398

Group type: EXPERIMENTAL
Intervention: First Fundal Height (FH(1))
Number of subjects: 1398

Group type: EXPERIMENTAL
Intervention: Algorithm (reference GA)
Number of subjects: 1398
Study: 12775735

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg daily
Number of subjects: 916

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg daily
Number of subjects: 916
Study: 10852793

Group type: EXPERIMENTAL
Intervention: Nedocromil (8 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nedocromil
Number of subjects: 24
Study: 9374925

Group type: EXPERIMENTAL
Intervention: Sulphasalazine (SSZ) 2000 mg daily (maximum 3000 mg)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 7.5 mg weekly (maximum 15 mg)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Combination of sulphasalazine and methotrexate (COMBI)
Number of subjects: 105
Study: 1525791

Group type: EXPERIMENTAL
Intervention: Cefaclor AF (750 mg twice daily)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Cefaclor (500 mg three times daily)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Cefaclor AF
Number of subjects: 266

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 266
Study: 3903579

Group type: EXPERIMENTAL
Intervention: Oral ritodrine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31237964

Group type: EXPERIMENTAL
Intervention: Pain at five to seven sites
Number of subjects: 450

Group type: COMPARATOR
Intervention: Pain at zero to two sites
Number of subjects: 450
Study: 29767743

Group type: EXPERIMENTAL
Intervention: Low-fat yogurt (339 g)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Soy pudding (324 g)
Number of subjects: 120
Study: 25777794

Group type: EXPERIMENTAL
Intervention: Dental support device (DSD)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (no DSD)
Number of subjects: 191
Study: 24357420

Group type: EXPERIMENTAL
Intervention: IV 2% lignocaine from induction until 1 h after surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: IP 0.2% lignocaine instillation in gallbladder fossa after removal of gallbladder
Number of subjects: 50
Study: 22607109

Group type: COMPARATOR
Intervention: Latanoprost 50 μg/mL
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Latanoprost 75 μg/mL
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Latanoprost 100 μg/mL
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Latanoprost 125 μg/mL
Number of subjects: 282
Study: 21121402

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 mcg, 6 hourly, max 4 doses)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol
Number of subjects: 258

Group type: COMPARATOR
Intervention: Oral misoprostol
Number of subjects: 258

Group type: COMPARATOR
Intervention: Vaginal misoprostol
Number of subjects: 258
Study: 17407170

Group type: EXPERIMENTAL
Intervention: 35% carbon dioxide challenge test
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Oral caffeine (480 mg) intake
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Responsive group (patients who had a panic attack during both tests)
Number of subjects: 83
Study: 16363297

Group type: EXPERIMENTAL
Intervention: Small volume at high concentration (5 mL of 0.75% levobupivacaine)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Large volume at low concentration (10 mL of 0.375% levobupivacaine)
Number of subjects: 69
Study: 16427409

Group type: EXPERIMENTAL
Intervention: Twist drill craniostomy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Bur hole or craniotomy
Number of subjects: 79
Study: 10775784

Group type: EXPERIMENTAL
Intervention: Three-component blood-stage malaria vaccine (recombinant proteins MSP1, MSP2, RESA with Montanide ISA720 adjuvant), injected twice (four weeks apart)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Adjuvant alone
Number of subjects: 12
Study: 8685289

Group type: EXPERIMENTAL
Intervention: Individual oriented psychosocial intervention (IPI)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Individual oriented psychosocial intervention plus behavioral family intervention (IPFI)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: In‐patient treatment with psychoeducation for parents followed by out‐patient psychosocial intervention
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Additional family intervention
Number of subjects: 76
Study: 1519714

Group type: EXPERIMENTAL
Intervention: Phenytoin (5 mg.kg‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tubocurarine (3 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 60
Study: 6524312

Group type: EXPERIMENTAL
Intervention: 0.1%, 1.0%, and 10% phenylephrine eye drops
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phenylephrine treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study: 31232721

Group type: EXPERIMENTAL
Intervention: Vaginal estrogen (via ring or cream)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 35
Study: 31565781

Group type: EXPERIMENTAL
Intervention: Investigational drug
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 30954205

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied to one side after osteotomy and before fixation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control side (no PRF applied)
Number of subjects: 21
Study: 26852139

Group type: EXPERIMENTAL
Intervention: Amifampridine phosphate (Firdapse(®))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25372452

Group type: EXPERIMENTAL
Intervention: 0.5% povidone‐iodine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Chlorhexidine in an alcohol base (Chemisol)
Number of subjects: 70
Study: 22745272

Group type: EXPERIMENTAL
Intervention: EPO-α (n=36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (n=36)
Number of subjects: 72
Study: 21244725

Group type: EXPERIMENTAL
Intervention: PURETHAL Mites (PM)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 18036873

Group type: EXPERIMENTAL
Intervention: Verteporfin infusion followed by standard light application at 15 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verteporfin infusion followed by delayed light application at 30 minutes
Number of subjects: 60
Study: 16282835

Group type: EXPERIMENTAL
Intervention: PAX + sulpiride (100 mg/d)
Number of subjects: 41

Group type: COMPARATOR
Intervention: PAX (10-40 mg/d)
Number of subjects: 41
Study: 11902848

Group type: EXPERIMENTAL
Intervention: Health Works for Women (HWW) intervention
Number of subjects: 538

Group type: COMPARATOR
Intervention: Delayed intervention (control)
Number of subjects: 538
Study: 10411058

Group type: EXPERIMENTAL
Intervention: Urethral occlusive device (FemAssist)
Number of subjects: 57
Study: 7744584

Group type: EXPERIMENTAL
Intervention: Combination of chemotherapy and endocrine manipulation for node-negative breast cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy for node-positive disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed reintroduction of chemotherapy after initial cytotoxic treatment for node-positive disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection for elderly patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant treatment for breast cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pathological findings in node-negative disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: c-erbB-2 oncogene expression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patterns of relapse
Number of subjects: 0
Study: 31668965

Group type: EXPERIMENTAL
Intervention: Renshen Yangrong Tang (RSYRT) herbal extract granules, taken twice a day for six weeks.
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Renshen Yangrong Tang (RSYRT) herbal extract granules.
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (low dose of a single herb - huangqi, taken twice a day for six weeks).
Number of subjects: 83
Study: 31703669

Group type: EXPERIMENTAL
Intervention: Integrated treatment of HCV in PWID, which includes testing for HCV, assessing liver fibrosis, counselling, treatment delivery, follow-up, and evaluation in integrated substance use disorder treatment clinics.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care involving referral to further diagnostics, treatment, and treatment follow-up in a hospital outpatient clinic.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Integrated treatment of HCV in PWID.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care.
Number of subjects: 200
Study: 28625661

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle loading (IML) in normoxia
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle loading (IML) in hypoxia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hypoxia compared to normoxia
Number of subjects: 10
Study: 26020764

Group type: EXPERIMENTAL
Intervention: Diagnosis of diabetes mellitus
Number of subjects: 31227

Group type: EXPERIMENTAL
Intervention: Baseline fasting plasma glucose value increase by 1 mmol/L
Number of subjects: 31227

Group type: EXPERIMENTAL
Intervention: Baseline fasting plasma glucose value increase by 1 mmol/L (after adjustment)
Number of subjects: 31227
Study: 24016248

Group type: EXPERIMENTAL
Intervention: Statin-benzafibrate combination therapy (atorvastatin 20 mg QN + bezafibrate 200 mg BID)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Statin monotherapy (atorvastatin 20 mg QN or equivalent)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Statin-benzafibrate combination therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Statin monotherapy
Number of subjects: 104
Study: 21446859

Group type: EXPERIMENTAL
Intervention: Progressive resistance training 2 days per week for 10 weeks
Number of subjects: 30
Study: 18596116

Group type: EXPERIMENTAL
Intervention: Amiloride (10 mg daily for 6 weeks)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Lithium (control group)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Alternate psychotropic medications (control group)
Number of subjects: 87